% Expired Patents = 100.0

EPO Patents = 3

Forward Citations = 6

Loading Chart...

7 inventors (with patents filed for the assignee):

Vincent Gerusz (7 out of 13 patents)

Mayalen Oxoby (6 out of 7 patents)

Sonia Escaich (5 out of 7 patents)

4. Alexis Denis (5 out of 32 patents)

5. Yannick Bonvin (2 out of 4 patents)

6. Francois Moreau (2 out of 6 patents)

7. Fabien Faivre (1 out of 8 patents)

7 patents: Sort by Forward Citations

1. 9321769 - Heterocyclic acrylamides and their use as pharmaceuticals (2016-04-26),

2. 9272985 - Antibacterial hydroxyphenyl compound (2016-03-01),

3. 9051321 - Heterocyclic acrylamides and their use as pharmaceuticals (2015-06-09),

4. 8846711 - Heterocyclic acrylamides and their use as pharmaceuticals (2014-09-30),

5. 8722746 - Hydroxyphenyl derivatives and biological applications thereof (2014-05-13),

6. 8623865 - Acylpiperazinones and their use as pharmaceuticals (2014-01-07),

7. 8383621 - Acylpiperazinones and their use as pharmaceuticals (2013-02-26),

Company Overview

Fab Pharma S.a.s. is a pharmaceutical company specializing in the development and distribution of innovative and high-quality healthcare products. With a focus on research and development, Fab Pharma is committed to improving the lives of patients worldwide. Their mission is to provide safe and effective solutions to meet the evolving needs of healthcare professionals and patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#451 in Paris

#2,219 in France

Paris, France

Fab Pharma S.a.s.

Forward Citations = 6

7 inventors:

Vincent Gerusz (7 out of 13 patents)

Mayalen Oxoby (6 out of 7 patents)

Sonia Escaich (5 out of 7 patents)

4. Alexis Denis (5 out of 32 patents)

5. Yannick Bonvin (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fab Pharma S.a.s.. Retrieved from https://idiyas.com/company/fab-pharma-s-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]